摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-isobutyl-2-methyloctanamide

中文名称
——
中文别名
——
英文名称
N-isobutyl-2-methyloctanamide
英文别名
2-methyl-N-(2-methylpropyl)octanamide
N-isobutyl-2-methyloctanamide化学式
CAS
——
化学式
C13H27NO
mdl
——
分子量
213.363
InChiKey
XNYUCASDEHYYRT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    15
  • 可旋转键数:
    8
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.92
  • 拓扑面积:
    29.1
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

  • 作为产物:
    描述:
    辛烯一氧化碳异丁胺盐酸盐 在 2-(diphenylphosphanyl)-1-(2-methoxyphenyl)-1H-pyrrole 、 palladium dichloride 作用下, 以 四氢呋喃 为溶剂, 125.0 ℃ 、4.0 MPa 条件下, 反应 24.0h, 生成 N-isobutylnonanamideN-isobutyl-2-methyloctanamide
    参考文献:
    名称:
    烯烃选择性钯催化的氨基羰基化为支链酰胺
    摘要:
    首次开发了使用脂肪族胺对烯烃进行异选择氨基羰基化的通用有效方法。该工艺成功的关键是在存在PdX 2(X =卤化物)作为前催化剂的情况下使用特定的2-膦基取代的吡咯配体。大量的工业化和官能化烯烃与各种脂肪胺(包括氨基酸衍生物)反应,通常以较高的收率(高达99%)和区域选择性(b / l高达99:1)得到相应的支链酰胺。
    DOI:
    10.1002/anie.201605104
点击查看最新优质反应信息

文献信息

  • Dodecacarbonyltriruthenium catalysed carbonylation of amines and hydroamidation of olefins
    作者:Yasushi Tsuji、Tatsuya Ohsumi、Teruyuki Kondo、Yoshihisa Watanabe
    DOI:10.1016/s0022-328x(00)99635-9
    日期:1986.8
    benzylamine, N-benzylformamide was obtained in 77% yield. 1-Octene was hydroamidated with benzylamine to N-benzylnonanamide in 67% yield (the selectivity to its linear isomer was 81%). These reactions appear to include ruthenium carbamoyl complex as the common key intermediate.
    十二碳三钌(Ru 3(CO)12)是一种有效的均相催化剂前体,用于在一氧化碳压力为40 kg cm -2的条件下在120–180°C下进行胺的羰基化和烯烃的加氢酰胺化。通过苄胺的羰基化,以77%的产率获得了N-苄基甲酰胺。用苄胺将1-辛烯加氢酰胺化为N-苄基壬酰胺,产率为67%(其线性异构体的选择性为81%)。这些反应似乎包括钌氨基甲酰基络合物作为常见的关键中间体。
  • ACYLGUANIDINES FOR TREATING OSTEOARTHRITIS
    申请人:MERCK PATENT GMBH
    公开号:US20150361037A1
    公开(公告)日:2015-12-17
    The present invention relates to compounds of the formula (I) and in particular to medicaments comprising at least one compound of the formula I for use in the treatment and/or prophylaxis of physiological and/or pathophysiological conditions in the triggering of which cathepsin D is involved, in particular for use in the treatment and/or prophylaxis of osteoarthritis, traumatic cartilage injuries, arthritis, pain, allodynia or hyperalgesia.
    本发明涉及公式(I)的化合物,特别是涉及至少一种公式I化合物构成的药物,用于治疗和/或预防在其中天冬氨酸蛋白酶D参与的生理和/或病理生理状况,特别是用于治疗和/或预防骨关节炎、创伤性软骨损伤、关节炎、疼痛、触痛或过敏性疼痛。
  • 5-Substituted amino-4-hydroxy-pentanoic acid derivatives and their use
    申请人:Banyu Pharmaceutical Co., Ltd.
    公开号:EP0264106A2
    公开(公告)日:1988-04-20
    A 5-substituted amino-4-hydroxy-pentanoic acid derivative having the formula: wherein R¹ is a hydrogen atom, a lower alkoxycarbonyl group, an aryloxycarbonyl group, an aralkyloxycarbonyl group or a lower alkanoyl group which may be substituted by from one to three substituents selected from the group consisting of an amino group, a hydroxyl group, a carboxyl group, an aryloxy group, an aralkyloxycarbonylamino group, a lower alkoxycarbonylamino group wherein each of X¹ and X² which may be the same or different is a hydrogen atom, a lower alkyl group, an aryl group or an aralkyl group, or X¹ and X² form together with the adjacent nitrogen atom a 5- or 6-membered heterocyclic group which may further contain a hereto atom selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom which may further contain a double bond in its carbon chain, each of R², R³ and R⁵ which may be the same or different is a hydrogen atom, a lower alkyl group or a residue of an acidic, neutral or basic amino acid, R⁴ is a hydrogen atom or a lower alkyl group, R⁶ is a lower alkyl, cycloalkyl, cycloalkylalkyl or aralkyl group which is substituted by one or two hydroxyl groups, R⁷ is a hydroxyl group, a -OY group wherein Y is a lower alkyl group, an aryl group, an aralkyl group, a lower alkoxyalkyl group, a lower alkanoyloxyalkyl group, a lower alkoxycarbonyloxyalkyl group or a 1-phthalidyl group, wherein each of Y¹ and Y² which may be the same or different is a hydrogen atom, a lower alkyl group, an aryl group, an aralkyl group or a cycloalkyl group, or Y¹ and Y² form together with the adjacent nitrogen atom 5- or 5-membered heterocyclic group which may further contain a hereto atom selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom, and each of n and m which may be the same or different is 0 or 1.
    5-取代氨基-4-羟基戊酸衍生物,其式如下 其中 R¹为氢原子、低级烷氧基羰基、芳氧基羰基、芳烷氧基羰基或低级烷酰基,该低级烷酰基可被选自氨基、羟基、羧基、芳氧基、芳烷氧基羰基氨基、低级烷氧基羰基氨基所组成的组中的一至三个取代基所取代 其中 X¹ 和 X² 可相同或不同,各自为氢原子、低级烷基、芳基或芳烷基,或 X¹ 和 X² 与邻近的氮原子一起形成 5 或 6 元杂环基团,该杂环基团可进一步包含一个从氮原子、氧原子和硫原子组成的组中选出的同族原子,该杂环基团可进一步在其碳链中包含一个双键,R²、R³ 和 R⁵ 可相同或不同,各自为氢原子、R⁴ 是氢原子或低级烷基,R⁶ 是被一个或两个羟基取代的低级烷基、环烷基、环烷基烷基或芳烷基、R⁷ 是羟基、-OY 基团,其中 Y 是低级烷基、芳基、芳烷基、低级烷氧基烷基、低级烷酰氧基烷基、低级烷氧羰氧基烷基或 1-邻苯二甲酰基、 其中Y¹和Y²可以相同或不同,各自为氢原子、低级烷基、芳基、芳烷基或环烷基,或Y¹和Y²与相邻的氮原子一起形成5元或5元杂环基团,该杂环基团可进一步包含一个从氮原子、氧原子和硫原子组成的组中选出的同位原子,且n和m可以相同或不同,各自为0或1。
  • US9884814B2
    申请人:——
    公开号:US9884814B2
    公开(公告)日:2018-02-06
  • Selective Palladium-Catalyzed Aminocarbonylation of Olefins to Branched Amides
    作者:Jie Liu、Haoquan Li、Anke Spannenberg、Robert Franke、Ralf Jackstell、Matthias Beller
    DOI:10.1002/anie.201605104
    日期:2016.10.17
    general and efficient protocol for iso‐selective aminocarbonylation of olefins with aliphatic amines has been developed for the first time. Key to the success for this process is the use of a specific 2‐phosphino‐substituted pyrrole ligand in the presence of PdX2 (X=halide) as a pre‐catalyst. Bulk industrial and functionalized olefins react with various aliphatic amines, including amino‐acid derivatives
    首次开发了使用脂肪族胺对烯烃进行异选择氨基羰基化的通用有效方法。该工艺成功的关键是在存在PdX 2(X =卤化物)作为前催化剂的情况下使用特定的2-膦基取代的吡咯配体。大量的工业化和官能化烯烃与各种脂肪胺(包括氨基酸衍生物)反应,通常以较高的收率(高达99%)和区域选择性(b / l高达99:1)得到相应的支链酰胺。
查看更多